SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 39.06 |
| Enterprise Value ($M) | 38.14 |
| Book Value ($M) | 0.14 |
| Book Value / Share | 0.00 |
| Price / Book | 271.75 |
| NCAV ($M) | -1.36 |
| NCAV / Share | -0.04 |
| Price / NCAV | -28.80 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -59.93 |
| Return on Assets (ROA) | -1.03 |
| Return on Equity (ROE) | -1.04 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.55 |
| Current Ratio | 0.55 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1.64 |
| Assets | 3.14 |
| Liabilities | 3.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -4.43 |
| Net Income | -4.43 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -3.11 |
| Cash from Investing | 0.00 |
| Cash from Financing | -0.13 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,866 | 10,884 | 35.52 | |
| 1,122 | 6,173 | 18.18 | |
| 1,459 | 14,629 | 9.97 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EPIX – ESSA Pharma Inc. | EQ – Equillium, Inc. |
| ERNA – Ernexa Therapeutics Inc. | EVOK – Evoke Pharma, Inc. |
| EYEN – Eyenovia, Inc. | |
Financial data and stock pages provided by
Fintel.io